Rekah Pharmaceutical Industry Ltd. (TLV: REKA)

REKA Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	5.41	19.31	20.21	18.6	36.89	25.57
Short-Term Investments	0.04	-	-	-	-	-
Trading Asset Securities	-	0.04	0.08	0.04	0.04	0.04
Cash & Short-Term Investments	5.45	19.35	20.29	18.64	36.93	25.61
Cash Growth	-78.00%	-4.63%	8.83%	-49.52%	44.22%	-19.31%
Accounts Receivable	107.37	117.68	120.71	107.37	87.63	77.49
Other Receivables	12.81	8.67	6.83	2.25	1.98	2.89
Receivables	120.18	126.35	127.54	109.62	89.61	80.38
Inventory	99.37	96.6	92.2	89.61	97.85	69.19
Prepaid Expenses	-	1.94	1.83	1.42	0.71	0.74
Other Current Assets	-	7.09	1.28	2.37	2.25	1.77
Total Current Assets	225	251.33	243.14	221.66	227.35	177.68
Property, Plant & Equipment	148.25	154.62	163.21	177	181.82	181.02
Long-Term Investments	-	1.17	-	-	1.84	2.39
Goodwill	35.14	35.14	15.18	-	-	-
Other Intangible Assets	28.56	31.66	20.67	32.97	4.18	2.44
Long-Term Deferred Tax Assets	13.7	10.79	6.22	5.46	4.5	3.58
Other Long-Term Assets	0.01	0.01	0.01	0.01	0.01	0.01
Total Assets	451.83	484.72	448.42	437.09	419.69	367.11
Accounts Payable	96.93	78.89	81.21	57.44	59.89	47.03
Accrued Expenses	-	23.95	17.05	13.61	12.96	10.24
Short-Term Debt	22.36	3.12	-	0.01	5	0
Current Portion of Long-Term Debt	6.3	26.94	30.9	18.96	22.06	20.61
Current Portion of Leases	8.13	6.9	5.59	5.03	4.82	4.6
Current Income Taxes Payable	0.39	1.56	0.76	0.26	0.96	0.6
Current Unearned Revenue	-	0.13	0.1	0.25	0.88	0.47
Other Current Liabilities	16.92	2.31	3.44	3.04	1.7	1.13
Total Current Liabilities	151.03	143.79	139.03	98.61	108.26	84.68
Long-Term Debt	65.31	110.09	91.66	101.23	90.86	72.9
Long-Term Leases	36.48	38.76	37.55	40.6	43.6	46.15
Long-Term Deferred Tax Liabilities	5.62	6.03	2.75	3.16	-	-
Other Long-Term Liabilities	14.02	20.74	6.49	11.21	2	-
Total Liabilities	282.68	329.14	286.34	264.03	254.1	211.89
Common Stock	13.64	13.64	13.64	13.64	13.64	13.64
Additional Paid-In Capital	126.61	126.61	126.61	126.61	126.61	126.61
Retained Earnings	28.24	14.67	21.35	32.73	25.69	15.41
Treasury Stock	-0.51	-0.51	-0.51	-0.51	-0.51	-0.51
Comprensive Income & Other	1.12	1.12	0.93	0.54	0.09	-
Total Common Equity	169.1	155.54	162.03	173.01	165.53	155.16
Minority Interest	0.05	0.05	0.05	0.05	0.06	0.06
Shareholders' Equity	169.15	155.59	162.08	173.07	165.59	155.22
Total Liabilities & Equity	451.83	484.72	448.42	437.09	419.69	367.11
Total Debt	138.58	185.8	165.7	165.82	166.34	144.27
Net Cash (Debt)	-133.13	-166.45	-145.41	-147.18	-129.41	-118.66
Net Cash Per Share	-11.16	-14.58	-12.74	-12.89	-11.34	-10.40
Filing Date Shares Outstanding	11.43	11.41	11.41	11.41	11.41	11.41
Total Common Shares Outstanding	11.43	11.41	11.41	11.41	11.41	11.41
Working Capital	73.97	107.54	104.11	123.05	119.09	93
Book Value Per Share	14.80	13.63	14.19	15.16	14.50	13.59
Tangible Book Value	105.4	88.73	126.18	140.05	161.35	152.72
Tangible Book Value Per Share	9.22	7.77	11.05	12.27	14.14	13.38
Land	-	1.89	2.07	2.07	2.07	2.07
Buildings	-	117.94	124.71	122.66	119.21	116.97
Machinery	-	121.03	112.99	109.84	106.6	99.01
Leasehold Improvements	-	61.15	58.28	57.23	54.74	47.62

Source: S&P Capital IQ. Standard template. Financial Sources.